PKTX
Price:
$0.00945
Market Cap:
$3.47M
ProtoKinetix, Incorporated, a research and development stage bio-technology company, focuses on the scientific medical research of anti-freeze glycoproteins (AFGPs) or anti-aging glycoproteins (AAGPs). The company's AFGPs have commercial applications primarily in health care solutions. It develops AAGP to treat dry-eye diseases. It has a collaboration research agreement with the University of British Columbia. The company was formerly known as RJV Network, Inc. and changed its name to ProtoKinetix, Incorporated in July 2003. ProtoKinetix, Incorporated was incorporated in 1999 and is based in Marietta, Ohio.[Read more]
Industry
Biotechnology
IPO Date
2002-04-22
Stock Exchange
PNK
Ticker
PKTX
According to ProtoKinetix, Incorporated’s latest financial reports and current stock price. The company's current ROE is -91.48%. This represents a change of 300.86% compared to the average of -22.82% of the last 4 quarters.
The mean historical ROE of ProtoKinetix, Incorporated over the last ten years is -523.66%. The current -91.48% ROE has changed -82.53% with respect to the historical average. Over the past ten years (40 quarters), PKTX's ROE was at its highest in in the June 2015 quarter at 1.18%. The ROE was at its lowest in in the March 2020 quarter at -1287.76%.
Average
-523.66%
Median
-428.95%
Minimum
-1802.01%
Maximum
39.33%
Discovering the peaks and valleys of ProtoKinetix, Incorporated ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 140.55%
Maximum Annual ROE = 39.33%
Minimum Annual Increase = -888.92%
Minimum Annual ROE = -1802.01%
Year | ROE | Change |
---|---|---|
2023 | -95.32% | -78.94% |
2022 | -452.68% | -31.40% |
2021 | -659.92% | -63.38% |
2020 | -1802.01% | 140.55% |
2019 | -749.11% | 51.48% |
2018 | -494.52% | 22.04% |
2017 | -405.22% | 32.04% |
2016 | -306.89% | -1.10% |
2015 | -310.31% | -888.92% |
2014 | 39.33% | -45.80% |
The current ROE of ProtoKinetix, Incorporated (PKTX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-402.64%
5-year avg
-751.81%
10-year avg
-523.66%
ProtoKinetix, Incorporated’s ROE is less than Mymetics Corporation (11.39%), less than RegeneRx Biopharmaceuticals, Inc. (0%), less than RespireRx Pharmaceuticals Inc. (8.92%), less than Nascent Biotech, Inc. (1.03%), less than Nutra Pharma Corp. (0%),
Company | ROE | Market cap |
---|---|---|
11.39% | $152.00 | |
0% | $2.10K | |
8.92% | $292.33K | |
1.03% | $10.04M | |
0% | $759.68K |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like ProtoKinetix, Incorporated using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like ProtoKinetix, Incorporated or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is ProtoKinetix, Incorporated's ROE?
How is the ROE calculated for ProtoKinetix, Incorporated (PKTX)?
What is the highest ROE for ProtoKinetix, Incorporated (PKTX)?
What is the 3-year average ROE for ProtoKinetix, Incorporated (PKTX)?
What is the 5-year average ROE for ProtoKinetix, Incorporated (PKTX)?
How does the current ROE for ProtoKinetix, Incorporated (PKTX) compare to its historical average?